9,781 Shares in HCA Healthcare, Inc. $HCA Acquired by Sanctuary Advisors LLC

Sanctuary Advisors LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, HoldingsChannel.com reports. The firm bought 9,781 shares of the company’s stock, valued at approximately $3,814,000.

A number of other hedge funds also recently bought and sold shares of HCA. Nomura Asset Management Co. Ltd. raised its position in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares during the period. Sunbelt Securities Inc. increased its stake in shares of HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares in the last quarter. Advisors Capital Management LLC lifted its position in HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Finally, Liberty Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $1,905,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $428.90 on Wednesday. The firm’s fifty day moving average is $398.59 and its two-hundred day moving average is $442.83. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The company has a market cap of $92.86 billion, a P/E ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $6.84 earnings per share. As a group, analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent analyst reports. Morgan Stanley decreased their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Barclays reduced their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. KeyCorp dropped their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a report on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Finally, Oppenheimer cut their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.